Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Maintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer

Recruiting

3 1 1
Investigated Drugs:
+1
Phase 1b-2 Study of Elacestrant and Abemaciclib in Patients with Brain Metastases from ER-Positive, HER2-Negative Breast Cancer

Recruiting

1 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
- Elacestrant
- Abemaciclib
Study of inavolisib and fulvestrant for patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer
- Breast cancer metastatic
Investigated Drugs:
- Inavolisib
- Fulvestrant
Study of melphalan followed by eribulin, vinorelbine, or capecitabine versus eribulin, vinorelbine, or capecitabine alone for metastatic breast cancer patients with liver disease

Recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
A Study Comparing GDC-4198 Alone and with Giredestrant versus Abemaciclib with Giredestrant for Advanced Breast Cancer After Previous CDK4/6 Treatment

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Giredestrant
- Abemaciclib
A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Recruiting

3 1 1 1
Investigated Drugs:
+10
A Study of Datopotamab Deruxtecan for Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer That Did Not Respond to Hormone Therapy

Recruiting

2 1 1
Investigated Drugs:
- Datopotamab Deruxtecan
Study of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy

Recruiting

3 1 1 1
Investigated Drugs:
+8
Study of Trastuzumab Deruxtecan Blood Levels in Normal Weight and Overweight Patients with Metastatic Breast Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
- Trastuzumab Deruxtecan
Study of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer

Recruiting

2 1 1 1
Investigated Drugs:

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies